Basic Information

Drug ID DDPD00674 ...
Drug Name Galantamine
Molecular Weight 287.3535
Molecular Formula C17H21NO3
CAS Number 357-70-0
SMILES [H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
External Links
DRUGBANK DB00674
T3DB T3D2857
PubChem Compound 9651
PDR 933
Drugs.com Drugs.com Drug Page

Experimental Physicochemical Property

Not Available

Pharmacokinetic/ Toxicokinetic Property

Property Name Property Value Unit Raw Value Raw Unit Annotation Factor Reference
Bioavailability 95.0 % 90-100 % PO, oral; DRUGBANK
Bioavailability 100.0 % 100(91-110) % PO, oral; The Pharmacological Basis of Therapeutics
C Max 96.0 ng/ml 96±29 ng/ml PO, oral; Elderly; normal,healthy; The Pharmacological Basis of Therapeutics
T Max 1.0 h 1 h PO, oral; DRUGBANK
T Max 2.6 h 2.6±1.0 h PO, oral; Elderly; normal,healthy; The Pharmacological Basis of Therapeutics
Metabolic 75.0 % 75 % DRUGBANK
Clearance 3.9 L/h ~65 ml/min Renal clearance; DRUGBANK
Clearance 18.0 L/h ~300 ml/min Plasma clearance; DRUGBANK
Clearance 0.34 L/h/kg 5.7(5.0-6.3) ml/min/kg hydrolysis; hydrolysis; metabolism of ugt; hepatopathy,LD ↓ ;RD, renal impairment, Renal disease,including uremia ↓ ; The Pharmacological Basis of Therapeutics
Volume of Distribution 175.0 L 175.0 L Average volume of distribution; DRUGBANK
Volume of Distribution 2.6 L/kg 2.6(2.4-2.9) L/kg The Pharmacological Basis of Therapeutics
Half-life 7.0 h ~7 h terminal half-life; DRUGBANK
Half-life 5.7 h 5.7(5.2-6.3) h The Pharmacological Basis of Therapeutics
Toxicity LD50 75.0 mg/kg 75.0 mg/kg PO, oral; Components; Rattus, Rat; DRUGBANK
Toxicity LD50 75.0 mg/kg 75.0 mg/kg Rattus, Rat; T3DB
Eliminate Route 95.0 % ~95 % Urinary excretion; RD, renal impairment, Renal disease,including uremia ↓ ; DRUGBANK
Eliminate Route 5.0 % ~5 % Faeces excretion; DRUGBANK
Eliminate Route 30.4 % 30.4 % Urinary excretion; Unchanged drug; RD, renal impairment, Renal disease,including uremia ↓ ; DRUGBANK
Eliminate Route 20.0 % 20(18-22) % Urinary excretion; Unchanged drug; The Pharmacological Basis of Therapeutics
Protein Binding 18.0 % 18 % plasma proteins; DRUGBANK
Protein Binding 18.0 % 18 % The Pharmacological Basis of Therapeutics

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Brand Name Component Reference
Max dose for adults 24.0 mg/day 24 mg/day PO, oral Razadyne galantamine hydrobromide PDR
Max dose for elderly 24.0 mg/day 24 mg/day PO, oral Razadyne galantamine hydrobromide PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1